Calcitonin in the treatment of transient osteoporosis of the hip

Thurayya Arayssi, Hussein A. Tawbi, Ihab M. Usta, Mukbil H. Hourani

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Background: Transient osteoporosis of the hip (TOH) is a rare clinical disorder of unknown etiology characterized by hip pain and functional disability that resolve spontaneously in 6-24 months. Objectives: To report 2 patients with TOH during pregnancy who had rapid resolution of their illness with the use of calcitonin. To review the literature on TOH with special emphasis on its treatment. Methods: A MEDLINE search of studies published from 1966 to 2002 was performed to review treatment options for TOH and their effect on the natural history of the disease. Results: Our 2 patients developed hip pain during pregnancy with classical changes of TOH on MRI. Both patients received calcitonin, 1 during pregnancy and 1 postpartum with resolution of their symptoms within 6 to 9 weeks. Previous reports in the literature of treatment of TOH showed that antiresorptive agents (bisphosphonates and calcitonin) had shortened the duration of the illness compared with the natural history of the disease. Conclusions: TOH is an under-recognized entity associated with pain and disability. The use of antiresorptive agents may be of help in reducing the duration of the disease. Relevance: To increase the recognition of TOH and to consider therapeutic interventions to shorten the duration of the disease.

Original languageEnglish
Pages (from-to)388-397
Number of pages10
JournalSeminars in Arthritis and Rheumatism
Volume32
Issue number6
DOIs
Publication statusPublished - Jun 2003
Externally publishedYes

Fingerprint

Calcitonin
Osteoporosis
Hip
Bone Density Conservation Agents
Therapeutics
Pain
Pregnancy
Diphosphonates
MEDLINE
Postpartum Period

Keywords

  • Bisphosphonates, calcitonin, pregnancy
  • Transient osteoporosis

ASJC Scopus subject areas

  • Rheumatology
  • Anesthesiology and Pain Medicine

Cite this

Calcitonin in the treatment of transient osteoporosis of the hip. / Arayssi, Thurayya; Tawbi, Hussein A.; Usta, Ihab M.; Hourani, Mukbil H.

In: Seminars in Arthritis and Rheumatism, Vol. 32, No. 6, 06.2003, p. 388-397.

Research output: Contribution to journalArticle

Arayssi, Thurayya ; Tawbi, Hussein A. ; Usta, Ihab M. ; Hourani, Mukbil H. / Calcitonin in the treatment of transient osteoporosis of the hip. In: Seminars in Arthritis and Rheumatism. 2003 ; Vol. 32, No. 6. pp. 388-397.
@article{a1f30302c53d49b78944d3e1e32acd97,
title = "Calcitonin in the treatment of transient osteoporosis of the hip",
abstract = "Background: Transient osteoporosis of the hip (TOH) is a rare clinical disorder of unknown etiology characterized by hip pain and functional disability that resolve spontaneously in 6-24 months. Objectives: To report 2 patients with TOH during pregnancy who had rapid resolution of their illness with the use of calcitonin. To review the literature on TOH with special emphasis on its treatment. Methods: A MEDLINE search of studies published from 1966 to 2002 was performed to review treatment options for TOH and their effect on the natural history of the disease. Results: Our 2 patients developed hip pain during pregnancy with classical changes of TOH on MRI. Both patients received calcitonin, 1 during pregnancy and 1 postpartum with resolution of their symptoms within 6 to 9 weeks. Previous reports in the literature of treatment of TOH showed that antiresorptive agents (bisphosphonates and calcitonin) had shortened the duration of the illness compared with the natural history of the disease. Conclusions: TOH is an under-recognized entity associated with pain and disability. The use of antiresorptive agents may be of help in reducing the duration of the disease. Relevance: To increase the recognition of TOH and to consider therapeutic interventions to shorten the duration of the disease.",
keywords = "Bisphosphonates, calcitonin, pregnancy, Transient osteoporosis",
author = "Thurayya Arayssi and Tawbi, {Hussein A.} and Usta, {Ihab M.} and Hourani, {Mukbil H.}",
year = "2003",
month = "6",
doi = "10.1053/sarh.2002.50014",
language = "English",
volume = "32",
pages = "388--397",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Calcitonin in the treatment of transient osteoporosis of the hip

AU - Arayssi, Thurayya

AU - Tawbi, Hussein A.

AU - Usta, Ihab M.

AU - Hourani, Mukbil H.

PY - 2003/6

Y1 - 2003/6

N2 - Background: Transient osteoporosis of the hip (TOH) is a rare clinical disorder of unknown etiology characterized by hip pain and functional disability that resolve spontaneously in 6-24 months. Objectives: To report 2 patients with TOH during pregnancy who had rapid resolution of their illness with the use of calcitonin. To review the literature on TOH with special emphasis on its treatment. Methods: A MEDLINE search of studies published from 1966 to 2002 was performed to review treatment options for TOH and their effect on the natural history of the disease. Results: Our 2 patients developed hip pain during pregnancy with classical changes of TOH on MRI. Both patients received calcitonin, 1 during pregnancy and 1 postpartum with resolution of their symptoms within 6 to 9 weeks. Previous reports in the literature of treatment of TOH showed that antiresorptive agents (bisphosphonates and calcitonin) had shortened the duration of the illness compared with the natural history of the disease. Conclusions: TOH is an under-recognized entity associated with pain and disability. The use of antiresorptive agents may be of help in reducing the duration of the disease. Relevance: To increase the recognition of TOH and to consider therapeutic interventions to shorten the duration of the disease.

AB - Background: Transient osteoporosis of the hip (TOH) is a rare clinical disorder of unknown etiology characterized by hip pain and functional disability that resolve spontaneously in 6-24 months. Objectives: To report 2 patients with TOH during pregnancy who had rapid resolution of their illness with the use of calcitonin. To review the literature on TOH with special emphasis on its treatment. Methods: A MEDLINE search of studies published from 1966 to 2002 was performed to review treatment options for TOH and their effect on the natural history of the disease. Results: Our 2 patients developed hip pain during pregnancy with classical changes of TOH on MRI. Both patients received calcitonin, 1 during pregnancy and 1 postpartum with resolution of their symptoms within 6 to 9 weeks. Previous reports in the literature of treatment of TOH showed that antiresorptive agents (bisphosphonates and calcitonin) had shortened the duration of the illness compared with the natural history of the disease. Conclusions: TOH is an under-recognized entity associated with pain and disability. The use of antiresorptive agents may be of help in reducing the duration of the disease. Relevance: To increase the recognition of TOH and to consider therapeutic interventions to shorten the duration of the disease.

KW - Bisphosphonates, calcitonin, pregnancy

KW - Transient osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=0037633887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037633887&partnerID=8YFLogxK

U2 - 10.1053/sarh.2002.50014

DO - 10.1053/sarh.2002.50014

M3 - Article

VL - 32

SP - 388

EP - 397

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 6

ER -